Home

Wall Street declines after corporate results released

Purvi Agarwal and Johann M CherianReuters
The healthcare and tech sectors of Wall Street have made the largest losses at the start of trade. (AP PHOTO)
Camera IconThe healthcare and tech sectors of Wall Street have made the largest losses at the start of trade. (AP PHOTO) Credit: AAP

Wall Street's main indexes have fallen after US President Donald Trump's latest plans for pharma tariffs renewed worries of the effects of a trade war while some downbeat corporate results also weighed on investor sentiment.

Trump said late on Monday that he would announce pharma tariffs over the next two weeks, his latest action on levies that have roiled global financial markets over the past months.

Eli Lilly and Merck slipped about 2.4 per cent each while Pfizer was down 1.7 per cent after the news, which offset optimism around Trump's order aimed at reducing the approval time for pharmaceutical manufacturing plants.

Tariff-driven uncertainty has led consumers, businesses and even the US Federal Reserve to adopt a wait-and-watch mode as they struggle to navigate the tariffs and gauge their effects.

Ford Motor was the latest to suspend its annual outlook on Monday, joining a host of companies that withdrew their forecasts in April.

The car maker's shares reversed pre-market losses and were last up about 1.0 per cent in choppy trading.

"The biggest thing that stands out (this earnings season) is that CEOs are concerned about the uncertainty that's coming out (of) Washington DC with respect to global trade," said Adam Sarhan, chief executive of 50 Park Investments.

In early trading on Tuesday, the Dow Jones Industrial Average fell 435.80 points, or 1.06 per cent, to 40,783.03, the S&P 500 lost 61.98 points, or 1.10 per cent, to 5,588.40, and the Nasdaq Composite lost 240.21 points, or 1.35 per cent, to 17,604.03.

Most S&P 500 sectors were trading in the red, with healthcare and info tech the biggest losers, down 1.4 per cent and 1.7 per cent respectively.

Data analytics firm Palantir's shares fell 13.5 per cent to the bottom of the S&P 500 as investors were unimpressed by the company's modest revenue beat and in-line profit.

The Fed starts its two-day meeting on Tuesday, with the US central bank widely expected to stay put on interest rates.

Comments from policymakers will be scrutinised for any clues hinting at where they stand on monetary policy easing this year.

Traders expect about 79 basis points of policy easing by the end of 2025, with the first cut coming in July, according to data compiled by LSEG.

Trump's administration suggested last week that potential deals with trading partners were underway but markets have seen no concrete results on that front.

Wall Street closed lower on Monday, with the benchmark S&P 500 snapping a nine-session winning streak.

Against the uncertain trade backdrop, businesses boosted imports of goods in March, pushing the country's trade deficit to a record high of $US140.5 billion ($A218.0 billion).

DoorDash was down 7.5 per cent after the meal delivery firm said it would buy Deliveroo in a deal valuing the British rival at about 2.9 billion pounds ($A5.99 billion).

The US firm's quarterly revenue missed estimates, disappointing investors.

Declining issues outnumbered advancers for a 3.03-to-1 ratio on the NYSE and a 3.31-to-1 ratio on the Nasdaq.

The S&P 500 posted three new 52-week highs and six new lows while the Nasdaq Composite recorded nine new highs and 56 new lows.

Get the latest news from thewest.com.au in your inbox.

Sign up for our emails